BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//APPG for Prescribed Drug Dependence - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:APPG for Prescribed Drug Dependence
X-ORIGINAL-URL:https://prescribeddrug.org
X-WR-CALDESC:Events for APPG for Prescribed Drug Dependence
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20140330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20141026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20151029T110000
DTEND;TZID=Europe/Helsinki:20151030T170000
DTSTAMP:20260418T174119
CREATED:20150923T151631Z
LAST-MODIFIED:20150923T151631Z
UID:3538-1446116400-1446224400@prescribeddrug.org
SUMMARY:European Exchange study visit – Assuring quality in the reformed English NHS
DESCRIPTION:Dartford and Gravesham NHS Trust and the European Hospital and Healthcare Federation (HOPE) are hosting a European study visit on 29-30 October. \nThe English NHS has seen significant reforms in the past 5 years\, with an increasing focus on the quality of care provided. This study tour is aimed at senior clinical and managerial colleagues working in key operational\, policy or strategic roles in other European health systems. The two-day programme will provide delegates with a unique opportunity to meet and hear from a range of the most senior NHS leaders in England\, providing a deeper knowledge of the newly reformed NHS\, including how healthcare is assured and regulated from a professional\, organisational\, financial\, quality and safety perspective. \nMORE INFO \nPROGRAMME \nAPPLICATION FORM
URL:https://prescribeddrug.org/event/european-exchange-study-visit-assuring-quality-in-the-reformed-english-nhs/
LOCATION:Unnamed Venue\, Dartford\, United Kingdom
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20151028T090000
DTEND;TZID=Europe/Helsinki:20151028T170000
DTSTAMP:20260418T174119
CREATED:20160129T143954Z
LAST-MODIFIED:20160129T144009Z
UID:4088-1446022800-1446051600@prescribeddrug.org
SUMMARY:Multimorbidity Expert Meeting
DESCRIPTION:The main achievement during 2015 for the JA-CHRODIS work package on multimorbidity was the development of a framework for care of multimorbidity patients that can be applied across Europe. \nFirst\, we identified a list of 20 components across five domains from existing published comprehensive care programs for patients with multiple chronic conditions or frailty. An expert meeting was held in Brussels on October 28\, to discuss the components. Sixteen were selected after discussion. During the meeting the experts discussed the definition of the components\, aims\, key characteristics\, target population and relevance for patients with multimorbidity in order to develop a framework for care of multimorbidity patients\, including recommendations for delivery of system design\, decision support\, self management support\, clinical information systems\, and community resources. \nAn article has been produced to detail the results and conclusions of this meeting\, and has been reviewed\, edited and\, coauthored by all the experts\, entitled “Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases (CHRODIS)”. \nDownloads\nMinutes
URL:https://prescribeddrug.org/event/multimorbidity-expert-meeting/
LOCATION:Unnamed Venue\, Brussels\, Belgium
CATEGORIES:External,JA-CHRODIS,Meeting,WP6 - Multimorbidity
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20151027
DTEND;VALUE=DATE:20151028
DTSTAMP:20260418T174119
CREATED:20150720T113544Z
LAST-MODIFIED:20151221T143825Z
UID:3152-1445904000-1445990399@prescribeddrug.org
SUMMARY:Conference 'Which priorities for a European policy on multimorbidity?'
DESCRIPTION:[vc_row][vc_column width=”1/1″][mk_image src=”https://prescribeddrug.org/wp-content/uploads/2015/12/FotoJet-Collage.jpg” image_width=”600″ image_height=”470″ crop=”true” lightbox=”false” frame_style=”simple” target=”_self” caption_location=”inside-image” align=”left” margin_bottom=”0″][mk_padding_divider size=”40″][vc_column_text]Testimonials from multimorbid patients across Europe\, gathered by the European Patients’ Forum: \nAmanda Roberts\, United Kingdom \nCees Smit\, The Netherlands \nNina Baláčková\, Czech Republic \nWolfram Nolte\, Germany \nOana Maria Dan\, Romania \nMultimorbidity\, usually defined as the co-occurrence of two or more chronic conditions in one person\, has become the norm rather than the exception in primary care patients and is set to become more prevalent as our populations age. Multimorbidity is therefore a growing concern in our society and a challenge facing patients\, health professionals and health systems’ sustainability. \nUsing interactive formats\, this conference will provide a unique opportunity for healthcare professionals\, researchers\, policy-makers\, professionals from the pharmaceutical and ICT industry\, insurers and patient representatives to share experiences and existing knowledge on multimorbidity from regional models of care to research and decision-making tools. Building upon success stories and innovative practices\, participants will learn about the evidence base to support a change of mind-set from disease-oriented management to patient-oriented care. Participants will also be invited to reflect on how to overcome the barriers to achieve a common framework to work on multimorbidity. \nThe ‘Which priorities for a European policy on multimorbidity?’ conference is an invitation to everyone interested in management of patients with multiple illnesses to come together to: \n\nRaise awareness on the relevance and urgency to deal with multimorbidity\nShare experiences and practices in the management of multimorbidity\nLearn from innovative healthcare approaches\nExplore together how to address the barriers to address a common framework on multimorbidity\nCreate a common engagement across stakeholders to start addressing the issue at European level\n\nRegister here. \nMore information: here \nConference booklet[/vc_column_text][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/conference-which-priorities-for-a-european-policy-on-multimorbidity/
LOCATION:Thon Hotel EU\, Brussels
CATEGORIES:Conference,External
ORGANIZER;CN="European Commission - DG SANTE":MAILTO:MultimorbidityConference@propager.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20151020T090000
DTEND;TZID=Europe/Helsinki:20151021T160000
DTSTAMP:20260418T174119
CREATED:20150908T121031Z
LAST-MODIFIED:20160129T143018Z
UID:3425-1445331600-1445443200@prescribeddrug.org
SUMMARY:Diabetes: A Case Study on Strengthening Health Care for People with Chronic Diseases
DESCRIPTION:4th Meeting of work package 7\nOctober 20 – 21\, 2015 @ 9:00 – 16:00 • Ljubljana\, Slovenia\n \nNational Institute of Public Health of the Republic of Slovenia as a co-leader of the work package 7 of  the JA-CHRODIS organised the 4th meeting of the work package 7\, Diabetes: A Case Study on Strengthening Health Care for People with Chronic Diseases. \nThe objectives of this meeting were to make an update on activities of the WP7 and to present\, discuss\, and get the input from the Partners of WP7 and other participants. We answered questions such as: Where are we in Europe in relation to diabetes prevention and care? What do we do and does it give us some results or not? If yes\, what are the results? And if not\, what is the reason that lies behind? And most importantly – what can we learn from the past experiences related not only to diabetes but also to other chronic diseases\, and where should we go in the future? \nThe meeting was held in Ljubljana and dedicated to face-to-face discussions about previously mentioned questions and peak activities that will result in the final deliverables of our work package. \nDownloads\nSynthesis Report \nAgenda \nParticipants \nSWOT Report Successful Strategies \nPresentations\nEnrique Bernal-Delgado: Assessing practices on chronic diseases and chronic care \nVendula Blaya Nováková: SWOT Analysis_Diabetes strategy in the National Health System\, Spain \nManuel Botana: Galician Diabetes experiences \nBrigitte Domittner: SWOT Analysis Austria \nMarina Maggini & Jelka Zaletel: The process toward the recommendations \nMarina Maggini & Jelka Zaletel: Update of WP7 activities \nAngela Giusti: SWOT Analysis \nVanessa Moore: SWOT analysis from a gender perspective \nTheodoris Katsaras: SWOT Analysis Greece \nSilke Kuske: Systematic review on barriers for access to health care service \nAna Cristina Portugal: SWOT Analysis NDP Portugal \nMonica Sorensen: Prevention and management of diabetes in Norway \n 
URL:https://prescribeddrug.org/event/diabetes-a-case-study-on-strengthening-health-care-for-people-with-chronic-diseases/
LOCATION:Grand Hotel Union\, Miklošičeva 1\, Ljubljana\, 1000\, Slovenia
CATEGORIES:JA-CHRODIS,Meeting,WP7 - Diabetes type 2
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2015/09/CHRODIS_4th-Meeting-WP7-01.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20151014T100000
DTEND;TZID=Europe/Helsinki:20151014T161500
DTSTAMP:20260418T174119
CREATED:20150903T120132Z
LAST-MODIFIED:20150903T120132Z
UID:3377-1444816800-1444839300@prescribeddrug.org
SUMMARY:European Conference on Social Innovations for Healthy and Active Life Expectancy
DESCRIPTION:INNOVAGE organises the European Conference on Social Innovations for Healthy and Active Life Expectancy which will take place on 14 October 2015 in Brussels. The INNOVAGE project is focused on social innovations which will have a solid impact on improving the quality of life and well-being of older people. \nThe conference will present the project’s findings since 2012\, and will: \n\nShare the project’s activities and results\nHighlight the great potential of social innovations to both improve wellbeing and quality of life\nHelp to neutralise the negative aspects of ageing at the individual and societal levels\n\nFor further information and registration\, click HERE \nConference AGENDA
URL:https://prescribeddrug.org/event/european-conference-on-social-innovations-for-healthy-and-active-life-expectancy/
LOCATION:Renaissance Marriott Hotel\, Brussels\, Belgium
CATEGORIES:Conference,External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20151014
DTEND;VALUE=DATE:20151018
DTSTAMP:20260418T174119
CREATED:20150204T110642Z
LAST-MODIFIED:20160111T151409Z
UID:2083-1444780800-1445126399@prescribeddrug.org
SUMMARY:8th European Public Health Conference
DESCRIPTION:Between the 14th- 17th October\, 2015\, the 8th European Public Health (EPH) Conference took place in Milan\, Italy. The EPH Conference aims to contribute to the improvement of public health in Europe by offering a means for exchanging information and a platform for debate to researchers\, policy makers\, and practitioners in the field of public health and health services research as well as public health training and education in Europe. This year’s topic was: Health in Europe – from global to local policies\, methods and practices. \nView the programme at a glance here. \nPoster presentation “Joining forces across Europe to strengthen policies and approaches to prevent chronic disease: JA-CHRODIS”\, Caroline Costongs\, EuroHealthNet \nPPT presentation “Multimorbidity”\, Graziano Onder\, AIFA
URL:https://prescribeddrug.org/event/8th-european-public-health-conference/
LOCATION:MiCo\, Milan
CATEGORIES:Conference,External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150930
DTEND;VALUE=DATE:20151003
DTSTAMP:20260418T174119
CREATED:20150911T121813Z
LAST-MODIFIED:20151008T141404Z
UID:3477-1443571200-1443830399@prescribeddrug.org
SUMMARY:18th European Health Forum Gastein
DESCRIPTION:JA-CHRODIS was present at the 18th European Health Forum Gastein\, a three-day event held on 30 September to 2 October 2015 in Austria. The Forum is one of the most important health-related event in the European Union and a meeting point for experts from different fields within the health system. Co-leader of the multimorbidity work\, Rokas Navickas contributed to the session Facing Multimorbidity: Challenges and Responses on Day 2\, sharing essential facts and key trends of co-morbidity across Europe. Even though the consequences of multimorbidity are huge\, they have not been researched to a great extent and the tendency to exclude multimorbid patients from general clinical trials research is preventing to collect good data on them. \nClick to access Rokas Navickas’ presentation and press coverage of his session (Euractiv). Photos can be accessed here. \nRead more
URL:https://prescribeddrug.org/event/18th-european-health-forum-gastein/
CATEGORIES:Conference,External,WP6 - Multimorbidity
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150922T090000
DTEND;TZID=Europe/Helsinki:20150922T150000
DTSTAMP:20260418T174119
CREATED:20150903T091300Z
LAST-MODIFIED:20150910T100134Z
UID:3373-1442912400-1442934000@prescribeddrug.org
SUMMARY:EConDA final conference – dissemination of project results
DESCRIPTION:EConDA organises a final conference to disseminate the project results that will be held on 22th September\, 2015 in Brussels. Across Europe chronic diseases account for 86% of all deaths each year\, though rates vary between and within countries due to stark inequalities in health. Chronic diseases have a large impact on health care costs throughout the European Union. The EConDA project\, co-funded by the European Commission Consumers\, Health and Food Executive Agency\, has as its key aim to aid EU Member States to develop\, select and implement more cost-effective policies to improve chronic disease prevention and impact upon populations with the highest rates of premature deaths from chronic diseases and reduce health inequalities. \nThe conference will be preceded by 5 National Workshops: \n\n3 September\, Sofia – Bulgaria\n10 September\, The Hague – The Netherlands\n14 September\, Lisbon – Portugal\n16 September\, Warsaw – Poland\n18 September\, Kaunas – Lithuania\n\nFor further information and registration\, click HERE\n \nConference AGENDA
URL:https://prescribeddrug.org/event/econda-final-conference-dissemination-of-project-results/
CATEGORIES:Conference,External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150910
DTEND;VALUE=DATE:20150912
DTSTAMP:20260418T174119
CREATED:20150909T154022Z
LAST-MODIFIED:20150910T095957Z
UID:3450-1441843200-1442015999@prescribeddrug.org
SUMMARY:Conference of Baltic Family Doctors
DESCRIPTION:On 10-11 September 2015\, JA-CHRODIS will present on multimorbidity in Lithuania at the Conference of Baltic Family Doctors in Pärnu\, Estonia. The conference represents an excellent opportunity to share news and exchange personal experiences from the field of family medicine\, as well to provide valuable information and insights for family doctors and nurses. \nConference AGENDA\nRead MORE
URL:https://prescribeddrug.org/event/conference-of-baltic-family-doctors/
CATEGORIES:Conference,External,WP6 - Multimorbidity
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150902
DTEND;VALUE=DATE:20150905
DTSTAMP:20260418T174119
CREATED:20150909T145906Z
LAST-MODIFIED:20150909T145906Z
UID:3442-1441152000-1441411199@prescribeddrug.org
SUMMARY:II Ibero-American Congress of Epidemiology and Public Health
DESCRIPTION:On 2-4 September 2015\, JA-CHRODIS presented at the Second Ibero-American Congress held in Santiago de Compostela\, organised by the Spanish Society of Epidemiology\, the Spanish Society for Public Health and Health Administration and the Portuguese Association of Epidemiology. The Congress gathered approximately 800 health professionals to discuss the chronic challenge in epidemiology and public health. \nRead MORE
URL:https://prescribeddrug.org/event/ii-ibero-american-congress-of-epidemiology-and-public-health/
CATEGORIES:Conference,External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150902
DTEND;VALUE=DATE:20150904
DTSTAMP:20260418T174119
CREATED:20150720T111308Z
LAST-MODIFIED:20150910T095859Z
UID:3149-1441152000-1441324799@prescribeddrug.org
SUMMARY:6th EPHA Annual Conference
DESCRIPTION:“Towards a European Union for Health – From Health in All Policies to EU Governance for Health and Well-Being?”\nOne session will focus on “Europe and Chronic Diseases : challenges accepted\, lessons learned\, ways forward” and JA-CHRODIS will be present. \nMore information: here\nDraft Agenda: here
URL:https://prescribeddrug.org/event/6th-epha-annual-conference/
LOCATION:Residence Palace\, Brussels\, Belgium
CATEGORIES:Conference,External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150726
DTEND;VALUE=DATE:20150802
DTSTAMP:20260418T174119
CREATED:20150302T134226Z
LAST-MODIFIED:20150303T104258Z
UID:2307-1437868800-1438473599@prescribeddrug.org
SUMMARY:Observatory Venice summer school 2015 Integrated care: moving beyond the rhetoric
DESCRIPTION:Organised by the European Observatory on Health Systems and Policies in collaboration with the Veneto Region\, the Summer School 2015 is to take place from 26 July to 1 August 2015 in Venice\, Italy. \nThe six day course is an opportunity to interact and debate\, share experiences with senior policy makers\, planners and professionals in the field of integrated care. Participants will explore the latest evidence on integrated care\, critically analyse and discuss innovative approaches\, assess their effectiveness and implementation challenges – towards drawing practical policy and implementation lessons to inform better decision-making on delivery system reform that will positively impact the quality of care given resource constraints. \nEarly applications are encouraged as places are limited. More information will soon be available here (site under construction).
URL:https://prescribeddrug.org/event/observatory-venice-summer-school-2015-integrated-care-moving-beyond-the-rhetoric/
LOCATION:Venice – Italy\, Italy
CATEGORIES:Conference,External,Meeting
ATTACH;FMTTYPE=image/png:https://prescribeddrug.org/wp-content/uploads/2015/03/observatory2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150702T080000
DTEND;TZID=Europe/Helsinki:20150703T170000
DTSTAMP:20260418T174119
CREATED:20150602T140853Z
LAST-MODIFIED:20150910T095453Z
UID:2911-1435824000-1435942800@prescribeddrug.org
SUMMARY:WP7 Meeting
DESCRIPTION:Work package 7 (Type 2 Diabetes) held their third partners’ meeting in Rome on the 2nd-3rd July 2015. The objective of this 3rd meeting  was to present an update of the work package activities\, to exchange and receive the contribution from  the participants\, to improve the collaboration among all the partners towards achieving the objectives of the WP7. \nMeeting Agenda\nList of Participants \n3rd WP7 Meeting Report \nMeeting Presentations\nConsensus Process – M. Maggini \nEIP-AHA B3 Maturity Model – T. Vontetsianos \nEMPATHiE Tender – D. Somekh \nEUBIROD Registry – M. M. Benedetti \nEWMA-J.Kristensen \nHealth Care Resources – Z.Visockiene \nItalian Commitment on Diabetes – R. D’Elia \nPatient Empowerment – V.Strammiello \nQ. Results – Prevention & Management of Diabetes – F.Lombardo \nQ. Results – Prevention & Management of Diabetes – J.Lindström \nQ. Results – Prevention & Management of Diabetes – U.Rothe \nQuality Criteria – M.Sørensen \nQuality Indicators for Diabetes Prevention Programs – J.Lindström \nRw of Indicators – Quality Criteria – U.Rothe \nSWOT Analysis – A.Giusti \nWP2 – Communication – A.Gallinat \nWP7 Next Steps – M.Maggini; J-Zaletel \nWP7 Progress – M.Maggini; J.Zaletel
URL:https://prescribeddrug.org/event/wp7-meeting/
CATEGORIES:Meeting,WP7 - Diabetes type 2
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150611T080000
DTEND;TZID=Europe/Helsinki:20150612T170000
DTSTAMP:20260418T174119
CREATED:20150602T140604Z
LAST-MODIFIED:20160118T150509Z
UID:2910-1434009600-1434128400@prescribeddrug.org
SUMMARY:6th EB Meeting
DESCRIPTION:[vc_row][vc_column][vc_column_text]The JA-CHRODIS Executive Board met for the 6th time during the course of the Joint Action. This time we met in Treviso (Italy) between 11th-12th Meeting documents will be for download here as soon as they are available. \n  \n[/vc_column_text][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]\n11-12 June Executive Board Meeting\nAgenda \nMeeting Minutes \nPresentations\nOverview \nStrategic Decisions \nPriorities[/vc_column_text][mk_gallery images=”3142\,3141\,3140\,3139\,3138″ column=”3″ height=”250″ frame_style=”simple” disable_title=”false” image_quality=”1″ pagination=”false” count=”10″ pagination_style=”1″ order=”ASC” orderby=”date”][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/6th-eb-meeting/
ATTACH;FMTTYPE=image/png:https://prescribeddrug.org/wp-content/uploads/2014/07/CHRODIS_100mmlogo_RGB.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150610T120000
DTEND;TZID=Europe/Helsinki:20150610T140000
DTSTAMP:20260418T174119
CREATED:20150608T114549Z
LAST-MODIFIED:20150608T114549Z
UID:2983-1433937600-1433944800@prescribeddrug.org
SUMMARY:ECRPA Launch Event
DESCRIPTION:Join ECRPA in their launch event to raise awareness for End Stage Renal Disease (ESRD) which is a common occurrence in 1 out of 10 Europeans. This occurs as a result of most Chronic Kidney Disease (CKD) patients being unaware of their condition. No signs or symptoms of CKD are shown at an early stage\, most patients learn about their condition once 50-75% of their kidney function has already been destroyed\, making ESRD imminent. Raising awareness for this “silent epidemic”is highly important as it presents a major challenge for the aging European population\, as well as for the already over-stretched EU health systems.\n\nClick here for the registration form.
URL:https://prescribeddrug.org/event/ecrpa-launch-event/
LOCATION:Sofitel Brussels Europe\, Place Jourdan 1\, Brussels\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150610
DTEND;VALUE=DATE:20150611
DTSTAMP:20260418T174119
CREATED:20150910T160240Z
LAST-MODIFIED:20150911T082824Z
UID:3463-1433894400-1433980799@prescribeddrug.org
SUMMARY:2nd WP6 Partners Meeting
DESCRIPTION:On the 10th June 2015\, the JA-CHRODIS partners working on multimorbidity held their second partners’ meeting in Treviso\, Italy. The meeting provided partners with an opportunity to review the activities performed during the first year of JA-CHRODIS\, to assess the ongoing works and to plan the next steps for future action. Considerable time was also devoted to the discussion of performed and planned activities and to the presentation of new proposals. \nDOWNLOADS\nAgenda \nMeeting minutes \nPRESENTATIONS\nTask 1 – Results – F. Mammarella \nTask 1 – Identifying target groups \nTask 2 – Care pathways \nTask 2 – Review existing care \nTask 3 – Overview
URL:https://prescribeddrug.org/event/2nd-wp6-partners-meeting/
CATEGORIES:Meeting,WP6 - Multimorbidity
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150603T093000
DTEND;TZID=Europe/Helsinki:20150603T183000
DTSTAMP:20260418T174119
CREATED:20150401T142352Z
LAST-MODIFIED:20150707T155500Z
UID:2468-1433323800-1433356200@prescribeddrug.org
SUMMARY:Innovative Financing Opportunities in Active & Healthy Ageing
DESCRIPTION:The European Commission\, DG SANTE is organising the Conference ‘Innovative Financing Opportunities for Active & Healthy Ageing’ on the 3rd June 2015. The Conference will look at the issue of how to practically leverage public and private financial instruments and maximise synergies in the area of active & healthy ageing. In particular\, the Conference will focus on the EU financial instruments\, Investment plan for the EU\, joint-procurement of innovative solutions\, and new ways of public-private co-investments in health. The Conference will feature speakers and panellists discussing the synergies in the European Structural and Investment Funds and Horizon 2020\, public private partnerships\, social innovation and alternative financing means. \nThe European Commission’s Investment Plan for the EU seeks to encourage public and private investments in specific projects which will deliver in key areas such as knowledge\, innovation and the digital economy; in this respect the Conference would discuss building up cases addressing innovation on active and healthy ageing in the project pipeline of the Investment Plan. \nSome of the key questions the Conference will seek to address are: What can policy makers and governments at regional\, national and EU level do more to help? How to best mobilise investments\, also from the private sector? \nBuilding on the European Innovation Partnership on Active & Healthy Ageing\, the Conference will bring together the private sector and public sector working on solutions for financing of active & healthy ageing projects. \n 
URL:https://prescribeddrug.org/event/innovative-financing-opportunities-in-active-healthy-ageing/
LOCATION:Residence Palace\, Brussels\, Belgium
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/png:https://prescribeddrug.org/wp-content/uploads/2015/04/event-june2015.png
ORGANIZER;CN="European Commission - DG SANTE":MAILTO:MultimorbidityConference@propager.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150526T080000
DTEND;TZID=Europe/Helsinki:20150526T170000
DTSTAMP:20260418T174119
CREATED:20150602T140137Z
LAST-MODIFIED:20150602T140231Z
UID:2903-1432627200-1432659600@prescribeddrug.org
SUMMARY:WP5 Partners Meeting
DESCRIPTION:[vc_row][vc_column][vc_column_text]The third work meeting of work package 5 (Health Promotion) took place in Cologne\, Germany\, on 26 May 2015. WP5 is led by BZgA in cooperation with EuroHealthNet. \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]WP5 Meeting Presentations \n Dmitrakaki Task 3 Identification of GP \nEuroHealthNet Study Visit \nFinal Agenda WP5 Meeting Cologne \nYPE Projects So Far \nBZgA Overview Delphi Criteria \nBZgA Update WP5[/vc_column_text][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/wp5-partners-meeting/
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2014/07/NEWS_WP5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150520T090000
DTEND;TZID=Europe/Helsinki:20150521T140000
DTSTAMP:20260418T174119
CREATED:20150508T150506Z
LAST-MODIFIED:20150508T150506Z
UID:2805-1432112400-1432216800@prescribeddrug.org
SUMMARY:
DESCRIPTION:Conference on Patient Empowerment:\n“Empowered Patients are an Asset to Society”\n20-21 May\, 2015\, Brussels \nOrganised by the European Patients Forum and the Robert Bosch Stiftung \nFor more information\, see: http://www.eu-patient.eu/Events/upcoming-events/conference-on-patient-empowerment/
URL:https://prescribeddrug.org/event/2805/
LOCATION:Thon Hotel EU\, Brussels
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2015/05/patient-empowerment-e1431096471774.jpg
ORGANIZER;CN="V%C3%A9ronique Tarasovici":MAILTO:veronique.tarasovici@eu-patient.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150514
DTEND;VALUE=DATE:20150517
DTSTAMP:20260418T174119
CREATED:20150204T104827Z
LAST-MODIFIED:20150323T132531Z
UID:2076-1431561600-1431820799@prescribeddrug.org
SUMMARY:EuroPRevent
DESCRIPTION:The European Association for Cardiovascular Prevention and Rehabilitation is organising the EuroPRevent 2015 14-16th May in Lisbon\, Portugal\, where leading experts will get together in an international forum to present their research and share knowledge. The theme of the 2015 congress is: Addressing Inequalities in Cardiovascular Health. \nRegister here. \nAccess the programme here.
URL:https://prescribeddrug.org/event/ehealth-week/
LOCATION:Lisbon – Portugal\, Lisbon\, Portugal
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/gif:https://prescribeddrug.org/wp-content/uploads/2015/02/EuroPRevent.gif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150423T080000
DTEND;TZID=Europe/Helsinki:20150424T170000
DTSTAMP:20260418T174119
CREATED:20150602T134026Z
LAST-MODIFIED:20150602T140418Z
UID:2902-1429776000-1429894800@prescribeddrug.org
SUMMARY:WP4/5 1st Delphi meeting
DESCRIPTION:On 23rd and 24th April\, work package 4 (Knowledge Platform) together with work package 5 (Health Promotion) organised a face-to-face meeting of experts in the area of health promotion and primary prevention. This meeting was part of the Delphi process to decide on specific criteria and weights given to them to evaluate good practices criteria in this area. Outcomes of these successful discussions will be available soon.
URL:https://prescribeddrug.org/event/wp45-1st-delphi-meeting/
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2014/07/NEWS_WP7.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150421T100000
DTEND;TZID=Europe/Helsinki:20150421T163000
DTSTAMP:20260418T174119
CREATED:20150325T105122Z
LAST-MODIFIED:20150325T111041Z
UID:2328-1429610400-1429633800@prescribeddrug.org
SUMMARY:Active\, healthy ageing in the EU: Transforming care\, growing the silver economy
DESCRIPTION:The Public Policy Exchange organises an international symposium on active and healthy ageing on 21 April 2015 in Brussels\, Belgium.\nThis event aims to provide an opportunity to discuss the different ways healthy and active ageing can be encouraged to ensure the well-being and engagement of the elderly in European societies. Participants will explore practical solutions to some of the issues associated with an ageing population\, understand the implications for local\, regional and national authorities\, and assess innovative ideas in the field of age friendly environments and personal health management. \nFor further information and registration\, click here.
URL:https://prescribeddrug.org/event/active-healthy-ageing-in-the-eu-transforming-care-growing-the-silver-economy/
LOCATION:Thon Hotel Brussels City Center\, Avenue du Boulevard 17\, 1210 Brussels\, Brussels\, Belgium
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/png:https://prescribeddrug.org/wp-content/uploads/2015/02/active-healthy-ageing-1-e1425047456339.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150325
DTEND;VALUE=DATE:20150328
DTSTAMP:20260418T174120
CREATED:20150122T155446Z
LAST-MODIFIED:20150205T124540Z
UID:1762-1427241600-1427500799@prescribeddrug.org
SUMMARY:15th International Conference for Integrated Care
DESCRIPTION:The International Foundation of Integrated Care (IFIC)\, in partnership with NHS24 and the Joint Improvement Team of the Scottish Government\, present the 15th International Conference for Integrated Care “Complex Needs\, Integrated Solutions: Engaging\, empowering and enabling people for active and healthy living” to take place in Edinburgh\, Scotland\, on 25-27 March 2015. \nThe aim of this conference is to exchange knowledge\, experience and new ideas in the design and delivery of integrated health and social care. The key themes of the conference are \n\nEngagement and co-production with individuals\, carers\, families\, communities\, care workers and decision makers\nTackling multimorbidities\, health inequalities and complexity with Integrated Care\nTransforming care systems: evaluation and continuous improvement\nDigital health and innovation\n\nFor more information and registration\, click here. \nAccess the agenda here.
URL:https://prescribeddrug.org/event/future-test-event-1/
LOCATION:Sheraton Grand Hotel\, Edinburgh
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/png:https://prescribeddrug.org/wp-content/uploads/2015/01/15-conference-edimburg.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150309
DTEND;VALUE=DATE:20150311
DTSTAMP:20260418T174120
CREATED:20150120T085612Z
LAST-MODIFIED:20150325T162245Z
UID:1971-1425859200-1426031999@prescribeddrug.org
SUMMARY:European Summit on Innovation for Active and Healthy Ageing
DESCRIPTION:The Summit on Innovation for Active and Healthy Ageing aims to engage Europe’s policy\, services and market leaders to co-create a shared vision on how Europe can address the challenges and seize the opportunities arising from demographic change through ICT and innovation and in that way contribute to economic recovery. \nCentral topic: how can technology\, innovation and new ways of cooperation help Europe to turn this major challenge into an opportunity? Live demonstrations\, sand pits and an interactive exhibition will show in action what is being discussed and highlighted in thematic debates and knowledge-sharing sessions. A wide variety of meetings and side-events with one goal: to turn the opportunities of demographic ageing into growth and jobs for Europe. Several European Commissioners\, national ministers\, regional authorities and leaders from industry\, including SMEs and startups\, as well as civil society will take the floor and lead the debates. \nThe EU population is changing dramatically because of a higher life expectancy and a lower fertility: longer lives and fewer newborns. The number of European citizens over 80 will double by 2025 while the labour market is shrinking. Demographic change constitutes a colossal societal challenge and affects everyone. The ageing of our population can undermine the foundations of Europe’s health and social care systems. Our labour markets\, workforce and overall our cohesion as a society is at risk as the ratio of active vs. inactive people is shifting dramatically. \nBut demographic change also offers new opportunities for innovation\, growth and societal transformation that can benefit many millions. In our fast-paced and interconnected world\, driven by breakthrough technologies\, the right innovations for active and healthy ageing can help our citizens stay active and independent for more years\, while savings costs for governments and creating profits for businesses. A Digital Single Market can support a fairer\, more sustainable and prosperous society and the opportunities offered by the Silver Economy are immense. \nClick here to access the presentations and find out about the conclusions.
URL:https://prescribeddrug.org/event/european-summit-on-innovation-for-active-and-healthy-ageing/
LOCATION:The Square\, Mont des Arts\, Brussels\, Belgium
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2015/01/ageing_summit_banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150220T093000
DTEND;TZID=Europe/Helsinki:20150220T143000
DTSTAMP:20260418T174120
CREATED:20150602T133113Z
LAST-MODIFIED:20150608T121356Z
UID:2887-1424424600-1424442600@prescribeddrug.org
SUMMARY:WP5 2nd Partners' Meeting
DESCRIPTION:[vc_row][vc_column width=”1/1″][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]\nAgenda \nMinutes \nList of Participants \n  \nPresentations \n  \nIntroduction Presentation \nPresentation Sociaal Vitaal \nOvercoming Obesity \nTask4SMLPC \nTemplate Identifications of GP examples \nWP5 Chosen Example \nWP7 and WP5 \nCHRODIS Italian – Risk \nCountry Comparison \nEHNet Country Review \nFirst GP Spain – CHRODIS[/vc_column_text][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/wp5-2nd-partners-meeting/
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2014/07/NEWS_WP5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150219T130000
DTEND;TZID=Europe/Helsinki:20150219T160000
DTSTAMP:20260418T174120
CREATED:20150408T124540Z
LAST-MODIFIED:20151215T100643Z
UID:2565-1424350800-1424361600@prescribeddrug.org
SUMMARY:2nd Stakeholder Forum
DESCRIPTION:[vc_row][vc_column][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]Between 17th and 19th February 2015\, JA-CHRODIS held its second Consortium meeting in Brussels\, Belgium. This involves the fifth Executive Board meeting (17th February) and the General Assembly with all Associated and Collaborating Partners (19th February). Alongside\, both the Advisory Board and Governing Board held their first meetings on the 18th February. \nIf you have any questions\, please don’t hesitate to contact the coordination team at INFO@CHRODIS.EU! \n  \n19th February – 2nd Stakeholder Forum\nVenue: Husa President Park Hotel\, Room Fabiola (Brussels\, Belgium) \nAgenda \nInvitation Letter \nPractical Information \nReport \nEvaluation Report \nBackground meeting paper \n\nEIP on AHA presentation at 2nd JA-Chrodis SF\nJA- Chrodis_Challenges for 2015\nKeynote presentation\nWP2-dissemination of the JA\nWP4-Platform for Knowledge Exchange (PKE)\nWP6-Multimorbidity\nWP7-diabetes as a case study\n\n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mk_gallery images=”2443\,2442\,2441\,2440\,2439″ column=”3″ height=”110″ frame_style=”simple” disable_title=”false” image_quality=”2″ pagination=”false” count=”10″ pagination_style=”1″ order=”ASC” orderby=”date”][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/2nd-stakeholder-forum-draft/
LOCATION:Husa President Park Hotel\, Brussels\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2015/03/xIMG_4229.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20150219T090000
DTEND;TZID=Europe/Helsinki:20150219T130000
DTSTAMP:20260418T174120
CREATED:20150205T093706Z
LAST-MODIFIED:20151215T095920Z
UID:2124-1424336400-1424350800@prescribeddrug.org
SUMMARY:1st General Assembly
DESCRIPTION:[vc_row][vc_column width=”1/1″][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]Between 17th and 19th February 2015\, JA-CHRODIS held its second Consortium meeting in Brussels\, Belgium. This involved the fifth Executive Board meeting (17th February) and the General Assembly with all Associated and Collaborating Partners (19th February). Alongside\, both the Advisory Board and Governing Board held their first meetings on the 18th February. \nIf you have any questions\, please don’t hesitate to contact the coordination team at INFO@CHRODIS.EU! \nVenue: Husa President Park Hotel\, Room Fabiola (Brussels\, Belgium) \nAgenda \nDiscussion Groups \nPractical Information \nMinutes \nEvaluation Report \nPresentations\n\nFirst Year’s Results (Juan Riese\, ISCIII) \nDiscussion Group 1 – Dissemination and outreach\nDiscussion Group 2 – Care Delivery Models\nDiscussion Group 3 – Patient Empowerment\nDiscussion Group 4 – The Role of Health Promotion\nDiscussion Group 5 – Bridging the gap between knowledge and practice in management of chronic multimorbid patients\n\nSpeeches\n\nArévalo Gonzalo – Director of EU & International Projects Office at the National Institute of Health Carlos III (ISCIII)\nNicoline Tamsma – EuroHealthNet President\n\n[/vc_column_text][mk_gallery column=”3″ height=”110″ frame_style=”simple” disable_title=”false” image_quality=”2″ pagination=”false” count=”10″ pagination_style=”1″ order=”ASC” orderby=”date” images=”2414\,2413\,2412\,2411\,2410\,2409\,2408\,2407\,2406\,2405\,2404\,2403\,2402\,2401\,2400\,2399\,2398\,2397\,2396\,2395\,2394\,2393\,2392″ title=”Image Gallery”][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/1st-general-assembly/
LOCATION:Husa President Park Hotel\, Brussels\, Belgium
CATEGORIES:JA-CHRODIS,Meeting,WP1 - Coordination
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2015/02/xFull-room.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150218
DTEND;VALUE=DATE:20150219
DTSTAMP:20260418T174120
CREATED:20150408T121912Z
LAST-MODIFIED:20151126T152013Z
UID:2561-1424217600-1424303999@prescribeddrug.org
SUMMARY:1st Advisory Board & 1st Governing Board Meeting
DESCRIPTION:[vc_row][vc_column][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]Between 17th and 19th February 2015\, JA-CHRODIS held its second Consortium meeting in Brussels\, Belgium. This involves the fifth Executive Board meeting (17th February) and the General Assembly with all Associated and Collaborating Partners (19th February). Alongside\, both the Advisory Board and Governing Board  held their first meetings on the 18th February. If you have any questions\, please don’t hesitate to contact the coordination team at INFO@CHRODIS.EU! \nAdvisory Board Meeting\nAgenda\nBackground Meeting Paper\nMinutes \nSpeeches \n\nAlfonso Beltrán – Deputy Director of International Research and Programmes and External Relations ISCIII\n\nPresentations \n\nRole of the Advisory Board in JA-CHRODIS\nCoordination \nCommunication and Dissemination\nEvaluation\nHealth Promotion\nMultimorbidity\nDiabètes as a case study\n\nParticipants List \n\n  \nGoverning Board Meeting\nAgenda\nBackground Meeting Paper \nSpeeches \n\nAntonio Andreu – Director General of the National Institute of Health Carlos III (ISCIII)\nRubén Moreno – Secretary general of Health in Spain\n\nPresentation \nTerms of Reference for Governing Board \nParticipants List \nMinutes[/vc_column_text][mk_gallery images=”2438\,2437\,2436\,2435\,2434\,2433\,2432\,2431\,2430\,2429\,2428\,2427\,2426\,2425\,2424\,2423\,2422\,2421\,2420\,2419\,2418″ column=”3″ height=”110″ frame_style=”simple” disable_title=”false” image_quality=”2″ pagination=”false” count=”10″ pagination_style=”1″ order=”ASC” orderby=”date”][/vc_column][/vc_row][vc_row][vc_column width=”1/1″]\n[/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/1-advisory-board-draft/
LOCATION:Husa President Park Hotel\, Brussels\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2015/02/xIMG_3556-e1427467033906.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150217
DTEND;VALUE=DATE:20150218
DTSTAMP:20260418T174120
CREATED:20141104T120155Z
LAST-MODIFIED:20150429T134215Z
UID:2103-1424131200-1424217599@prescribeddrug.org
SUMMARY:5th Executive Board Meeting
DESCRIPTION:[vc_row][vc_column][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]Between 17th and 19th February 2015\, JA-CHRODIS held its second Consortium meeting in Brussels\, Belgium. This involves the fifth Executive Board meeting (17th February) and the General Assembly with all Associated and Collaborating Partners (19th February). Alongside\, both the Advisory Board and Governing Board held their first meetings on the 18th February. \nIf you have any questions\, please don’t hesitate to contact the coordination team at INFO@CHRODIS.EU! \n17th February – Executive Board Meeting\nAgenda \nParticipants List \nMinutes \n  \nPresentations \n\nWP1 – JA-CHRODIS – the first year experience\nWP7 – Ongoing activities for 2015\n\n[/vc_column_text][/vc_column][/vc_row]
URL:https://prescribeddrug.org/event/5th-eb-meeting/
LOCATION:Spanish Research Council (CSIC)\, Rue du Trône 62 \, Brussels\, 1050\, Belgium
CATEGORIES:JA-CHRODIS,Meeting,WP1 - Coordination
ATTACH;FMTTYPE=image/jpeg:https://prescribeddrug.org/wp-content/uploads/2014/11/x-5-Executive-Board.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150212
DTEND;VALUE=DATE:20150214
DTSTAMP:20260418T174120
CREATED:20150203T142201Z
LAST-MODIFIED:20150204T103058Z
UID:2044-1423699200-1423871999@prescribeddrug.org
SUMMARY:Workshop on Chronic Diseases and Healthy Ageing
DESCRIPTION:The Consumers\, Health\, Agriculture and Food Executive Agency (Chafea) organises a workshop on Chronic Diseases and Healthy Ageing to be hosted by the Netherlands. \nThis workshop aims to share the knowledge acquired through the chronic diseases and healthy ageing actions funded under the second Health Programme 2008-2013\, and at same time to demonstrate how their results can be used to improve EU countries capacities to respond to the challenges of chronic diseases and healthy ageing. It will involve speakers and experts from Belgium\, France\, Germany\, Ireland\, Luxembourg\, Spain\, the Netherlands and the United Kingdom and other EU countries. \nPublic health actions under the second Health Programme explored the status of EU\, national and regional policies and activities and the interaction of authorities\, patient organisations\, the medical and social sector\, industry and international organisations and their potential in better addressing specific major chronic diseases and healthy ageing across the lifecycle.
URL:https://prescribeddrug.org/event/workshop-chronic-diseases-healthy-ageing/
LOCATION:NH Den Haag Hotel\, The Hague\, Netherlands
CATEGORIES:Conference,External
ATTACH;FMTTYPE=image/png:https://prescribeddrug.org/wp-content/uploads/2015/01/CD-HA-workshop-banner.png
END:VEVENT
END:VCALENDAR